Evidence map›Paper›PMID 24498366›Full record

ArticlePloS one2014

Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination.

Bandita Bagchi, Ahmed Al-Sabi, Seshu Kaza, Dimitri Scholz, Valerie B O'Leary, J Oliver Dolly, Saak V Ovsepian

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Properties of Heterochannels Kv(1.1-1.2)International journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. KThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Radiochemical Synthesis and Evaluation of 3-[ACS chemical neuroscience · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Evaluation of the potassium channel tracer [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Bandita BagchiInternational Centre for Neurotherapeutics, Dublin City University, Glasnevin, Dublin, Republic of Ireland.
Ahmed Al-SabiInternational Centre for Neurotherapeutics, Dublin City University, Glasnevin, Dublin, Republic of Ireland.
Seshu KazaInternational Centre for Neurotherapeutics, Dublin City University, Glasnevin, Dublin, Republic of Ireland.
Dimitri ScholzConway Institute, University College Dublin, Belfield, Dublin, Ireland.
Valerie B O'LearyInternational Centre for Neurotherapeutics, Dublin City University, Glasnevin, Dublin, Republic of Ireland.
J Oliver DollyInternational Centre for Neurotherapeutics, Dublin City University, Glasnevin, Dublin, Republic of Ireland.
Saak V OvsepianInternational Centre for Neurotherapeutics, Dublin City University, Glasnevin, Dublin, Republic of Ireland ; Department of Biotechnology, Dublin City University, Glasnevin, Dublin, Republic of Ireland ; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ludwig-Maximilians-Universität München, Zentrum für Neuropathologie, Feodor-Lynen-Str. 23, Munich, Germany.
Dublin City University · IELudwig-Maximilians-Universität München · DEUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular determinants of abnormal propagation of action potentials along axons and ectopic conductance in demyelinating diseases of the central nervous system, like multiple sclerosis (MS), are poorly defined. Widespread interruption of myelin occurs in several mouse models of demyelination, rendering them useful for research. Herein, considerable myelin loss is shown in the optic nerves of cuprizone-treated demyelinating mice. Immuno-fluorescence confocal analysis of the expression and distribution of voltage-activated K⁺ channels (K(V)1.1 and 1.2 α subunits) revealed their spread from typical juxta-paranodal (JXP) sites to nodes in demyelinated axons, albeit with a disproportionate increase in the level of K(V)1.1 subunit. Functionally, in contrast to monophasic compound action potentials (CAPs) recorded in controls, responses derived from optic nerves of cuprizone-treated mice displayed initial synchronous waveform followed by a dispersed component. Partial restoration of CAPs by broad spectrum (4-aminopyridine) or K(V)1.1-subunit selective (dendrotoxin K) blockers of K⁺ currents suggest enhanced K(V)1.1-mediated conductance in the demyelinated optic nerve. Biophysical profiling of K⁺ currents mediated by recombinant channels comprised of different K(V)1.1 and 1.2 stoichiometries revealed that the enrichment of K(V)1 channels K(V)1.1 subunit endows a decrease in the voltage threshold and accelerates the activation kinetics. Together with the morphometric data, these findings provide important clues to a molecular basis for temporal dispersion of CAPs and reduced excitability of demyelinated optic nerves, which could be of potential relevance to the patho-physiology of MS and related disorders.

Indexed as

Action PotentialsAnimalsAxonsBrainCuprizoneDemyelinating DiseasesDisease Models, AnimalImmunoenzyme TechniquesKv1.1 Potassium ChannelKv1.2 Potassium ChannelMiceMice, Inbred C57BLMonoamine Oxidase InhibitorsMyelin SheathOptic NerveCuprizoneKv1.1 Potassium ChannelKv1.2 Potassium ChannelMonoamine Oxidase Inhibitors

Identifiers

PMID24498366
PMCPMC3912067
OpenAlexW2019612822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.